Data / Drug companies / BrightGene Bio-Medical Technology Co., Ltd.
BrightGene Bio-Medical Technology Co., Ltd.: 19 products in the FDA NDC directory, labeler code 62227
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
BrightGene Bio-Medical Technology Co., Ltd. (labeler code 62227) lists 19 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 24, 2026.
The request: Watch BrightGene Bio-Medical Technology Co., Ltd. (FDA labeler code 62227): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62227
- Products in commercial distribution
- 19
- Packages
- 19
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- January 12, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 19 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ferric carboxymaltose | 62227-029 | Powder | Bulk ingredients | August 24, 2026 |
| Cabergoline | 62227-028 | Powder | Bulk ingredients | January 28, 2026 |
| Fidaxomicin crystalline | 62227-027 | Powder | Bulk ingredients | June 6, 2025 |
| Selamectin | 62227-702 | Powder | Bulk ingredients | December 12, 2024 |
| Pimecrolimus | 62227-024 | Powder | Bulk ingredients | August 18, 2022 |
| Carboprost tromethamine | 62227-023 | Powder | Bulk ingredients | August 18, 2022 |
| Doramectin | 62227-701 | Powder | Bulk ingredients | August 20, 2021 |
| Caspofungin acetate | 62227-022 | Powder | Bulk ingredients | July 7, 2021 |
| Spinosad | 62227-020 | Powder | Bulk ingredients | April 28, 2021 |
| Everolimus | 62227-019 | Powder | Bulk ingredients | December 30, 2020 |
| Sugammadex sodium | 62227-016 | Powder | Bulk ingredients | February 25, 2020 |
| Fondaparinux sodium | 62227-006 | Powder | Bulk ingredients | February 1, 2019 |
| Argatroban | 62227-015 | Powder | Bulk ingredients | January 30, 2018 |
| Posaconazole | 62227-010 | Powder | Bulk ingredients | July 26, 2016 |
| Anidulafungin | 62227-007 | Powder | Bulk ingredients | July 27, 2015 |
| Posaconazole | 62227-008 | Powder | Bulk ingredients | May 2, 2015 |
| Micafungin sodium | 62227-005 | Powder | Bulk ingredients | July 10, 2014 |
| Fidaxomicin | 62227-003 | Powder | Bulk ingredients | March 12, 2014 |
| Posaconazole | 62227-001 | Powder | Bulk ingredients | January 12, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.